Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.23
+0.13 (2.13%)
At close: Jun 15, 2026, 4:00 PM EDT
6.21
-0.02 (-0.32%)
After-hours: Jun 15, 2026, 4:10 PM EDT

Precision BioSciences Revenue

Precision BioSciences had revenue of $10.84M in the quarter ending March 31, 2026, with 37,272.41% growth. This brings the company's revenue in the last twelve months to $45.07M, down -11.87% year-over-year. In the year 2025, Precision BioSciences had annual revenue of $34.26M, down -50.12%.

Revenue (ttm)
$45.07M
Revenue Growth
-11.87%
P/S Ratio
3.55
Revenue / Employee
$682,924
Employees
66
Market Cap
160.23M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202534.26M-34.43M-50.12%
Dec 31, 202468.70M19.97M40.98%
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M-531.00K-7.57%
Dec 31, 20167.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition